Purpose: To determine gene expression of five imprinted genes or transcripts from the 15qll-q13 chromosome region using reverse transcription polymerase chain reaction (RT-PCR) in a relatively large survey of Prader-Willi syndrome (PWS) and control subjects with several different chromosome 1 5 abnormalities. Methods: RT-PCR was undertaken on mRNA isolated from tissue (e.g., mostly lymphoblasts) from 38 PWS and 1 0 control subjects. DNA primers were used for five imprinted genes or transcripts (ZNF127, SNRPN, PAR5, IPW, and PAR1) from 15qll-€113 and fibrillin, a control gene from 15q21. Results: One PWS subject with maternal disomy 1 5 showed weak but detectable expression of PAR1, whereas SNRPN expression was detected in two PWS subjects [one with the 1 5 q l l --1 3 deletion and one with a t(15;15) karyotype and maternal disomy 151, and the remaining typical PWS subjects showed no expression of the imprinted genes or transcripts. Conclusion: No obvious clinical differences were identified in those PWS subjects with weak expression of genes compared with those showing no expression. Although the reason(s) for weak expression is unknown, possible explanations include relaxation of imprinting caused by failure to reset the imprinted genes or transcripts in the maternal germ line or by postzygotic gene expression or undetected chromosome 1 5 mosaicism in the deletion PWS subjects. The timing, tissue source, and other factors relating to partial expression of genes that are thought to be imprinted may play a role in clinical variability and allow for a better understanding of molecular mechanisms in PWS and other abnormalities of proximal chromosome 15q. Genetics in Medicine, 1999:1(4):141-145.
INTRODUCTION
Genetic disorders such as Angelman syndrome, Prader-Willi syndrome, Beckwith-Wiedemann syndrome, and several pediatric cancers are caused by genetic imprinting or an epigenetic process with non-Mendelian inheritan~e.l-~ Prader-Willi and Angelman syndromes were the first examples in humans of genetic imprinting or the differential expression of genetic information depending on the parent of rigi in.^-^ PWS is caused by deficiencies of the paternal specific human chromosome region 15qll-q13 by paternal deletion (about 70% of reported cases), maternal uniparental disomy 15, or imprinting m u t a t i o n~.~,~-~ Conversely, Angelman syndrome, an entirely different clinical syndrome, is usually caused by a maternal deletion of the 15qll-ql3 region and rarely caused by paternal uniparental disomy 15. PWS is characterized by infantile hypotonia, hypogonadism, early onset of childhood obesity, hyperphagia, mental deficiency, and minor a n~m a l i e s .~,~" PWS is the most common dysmorphic cause of marked obesity in human^.^ Several paternally expressed imprinted genes and transcripts have been identified from the 15q11-q13 region. These include ZNF127, NECDIN, SNRPN, PARS, IPW, and PAR^.^-^,'^-'^ These imprinted genes (SNRPN, IPW, ZNF127, NECDIN) and transcripts (PAR5 and PAR1) are thought to be silent on the maternal chromosome in the normal population and therefore not expressed in PWS subjects lacking this paternal chromosome 15 region.16 Gene expression data are lachng from surveys of PWS and control subjects with various genetic alterations of chromosome 15q11-q13. The lack of expression of these gene(s) seems to play a significant role in the causation of PWS. Herein, we report our experience with gene expression studies for the first time using reverse transcription polymerase chain reaction (RT-PCR) in a relatively large survey of previously diagnosed PWS and control subjects. A variety of genetic alterations involving chromosome 15 were present in the PWS or control subjects (e.g., 15q11-q13 deletions, maternal disomy 15, chromosome 15 translocations). The rationale for our study was to determine whether different genetic problems of the 15q11-q13 region affect the genetic expression of recognized imprinted genes and/or transcripts in this region in PWS or control subjects.
MATERIALS AND METHODS

Subjects
Thirty-eight PWS subjects (24 females and 14 males; age range: 1 4 3 years) were analyzed with various genetic defects of chromosome 15. They were available from a larger group of PWS subjects from Vanderbilt University. The PWS subjects were evaluated clinically by one of the authors (MGB) using the diagnostic criteria reported by Holm et al." and the diagnosis confirmed cytogenetically with fluorescence in situ hybridization (FISH) by routine genetic methods for the SNRPN probe and DNA microsatellites from the chromosome 15q11-q13 region and methylation testing of SNRPN with Southern hybridization or methylation specific PCR.18-22 There were no obvious differences in the methylation testing results with either Southern hybridization or methylation PCR of SNRPN in the diagnosis of PWS in our study.
Twenty-one PWS subjects showed the typical 15qll-q13 deletion and only one DNA band of maternal origin of the SNRPN gene by methylation PCR analysis consistent with the diagnosis of PWS. Eleven subjects had normal chromosomes and maternal disomy 15, including one adult female homozygous for 15q11-q13 DNA bands, whereas the other maternal disomy 15 subjects were heterozygous (all maternal disomy subjects showed only one DNA band of maternal origin of the SNRPN gene by methylation PCR analysis). Three subjects had translocations involving chromosome 15 [e.g., two translocation patients with a t(15;15) and maternal disomy, and only one DNA band of maternal origin of the SNRPN gene by methylation PCR analysis, and one translocation patient with a t(15;19) karyotype previously reported by Sun et al.23 with features consistent with PWS had normal methylation PCR findings (a maternal and a paternal DNA band of the SNRPN gene)]. Two PWS patients with nondeleted imprinting mutations reported previously by Ohta et a1.6 showed only one DNA band of maternal origin of the SNRPN gene by methylation PCR analysis. The remaining PWS subject had a submicroscopic deletion of chromosome 15 reported previously by Butler et al.19 and only one DNA band of maternal origin of the SNRPN gene by methylation PCR analysis. A control sample of ten subjects (6 females and 4 males; age range: 3-39 years) was selected from the general genetics clinic population at Vanderbilt University after informed consent. These control individuals were selected because of features suggestive of PWS such as obesity and mental deficiency or having various chromosome 15 abnormalities. For example, one of the control male subjects presented at 10 years of age with autism, severe mental retardation, and an extra bisatellited marker chromosome 15; one female subject at 6 years of age had mild learning impairment and behavior problems and a de novo duplication of the 15ql1-q13 region of maternal origin by DNA microsatellite studies; one female subject at 18 years of age presented with features consistent with Angelman syndrome; and one male subject at 4 years of age previously reported by Butler et al.24 had a de novo ring chromosome 15 of maternal origin. The remaining control subjects had normal chromosome findings and normal methylation DNA patterns using primer sequences from the SNRPN gene and PCR analysis as described by Kubota et al.*' and Muralidhar and Butler.12 As stated, several of the remaining control subjects selected for this analysis presented with obesity and mild mental retardation. One control subject was a 39-yearold father of a PWS child with an imprinting mutation reported by Ohta et aL6The father had a normal chromosome study including FISH analysis with the SNRPN probe, normal DNA microsatellite studies of 15q11-q13 loci, and normal methylation PCR analysis with the SNRPN gene.
Molecular genetics
Total mRNA was extracted from tissue sources from 48 individuals, including 38 PWS and 10 control subjects, using the Quickprep Micro mRNA purification kit from Pharmacia (Piscataway, NJ). Recently established short-term lyrnphoblastoid cell lines were analyzed from 43 subjects, short-term fibroblast cultures in three subjects, and autopsy tissue from the cerebellum in one PWS subject and in one control subject. The mRNA Imprinted genes in Prader-Willi syndrome Table 1 Primer sequences used to amplify the imprinted and internal control gene(s) (1-2 pg) was treated with DNase-I. The reverse transcription was performed using Superscript Preamplication System in a 20 ul volume with 100 ng of random hexamers in duplicate with one assay containing Superscript I1 enzyme (RT+ ) and the other assay with no enzyme (RT+) following the supplier's protocol (Gibco-BRL, Gaithersburg, MD). PCR was performed with positive and negative controls in a 25 ul volume containing 1 X GeneAmp PCR buffer with 1.5 mM MgC1, and 2 units of ArnpliTaq Gold DNA polymerase (Perkin Elmer, Norwalk, CT), 200 pM deoxynucleotide triphosphates, 2 ul of first strand cDNA, 0.7 pM of each respective gene-specific primers, and 0.35 pM control primers to amplify the internal control gene (e.g., fibrillin). The polymerase was activated at 94OC for 10 minutes, and DNA was amplified for 35 cycles at 94OC for 30 seconds, 56°C for 30 seconds, and 72°C for 30 seconds, and followed by a final extension at 72OC for 10 minutes. PCR products were separated using 1.5% agarose gel in 0.5X TBE buffer, stained with ethidium bromide, visualized under W illumination, and photographed. The methodolo was similar to that reported by Wevrick and FranckeZ5 and G." sed throughout for both PWS and control subjects. Primer sequences and expected band sizes in base pairs (bp) are shown in Table 1 .
RESULTS AND DISCUSSION
The RT-PCR results are summarized in Table 2 . Figure 1 shows representative findings of the imprinted genes and transcripts tested in our PWS and control subjects. Expression of fibrillin, the internal control gene, was detected in all 48 subjects, Table 2 RT-PCR results from the PWS and control subjects indicating that the RT-PCR assay was effective and robust. One PWS subject with a t(15;19) karyotype reported by Sun et al.23 showed expression of regions of all five imprinted genes and transcripts. One PWS patient with maternal disomy 15 and normal appearing chromosomes showed a weak but detectable expression signal for PAR1, whereas weak SNRPN expression was detected using primers E and L for exons 4 and 8,12 in two PWS subjects [one with the typical 15qll-q13 deletion and one with a t( 15; 15) karyotype and maternal disomy 15; see Figure  11 . No difference in gene expression was found by RT-PCR of mRNA isolated from lymphoblasts, fibroblasts, or brain tissue from autopsy specimens when comparing genes and transcripts from the 15qll-q13 region under imprinting control and using the fibrillin gene from chromosome 15q2126,27 as an internal control for our control subjects.
Interestingly, the SNRPN gene expression signal appeared stronger than predicted when comparing fibrillin gene expression for the control subject with the extra marker 15 chromosome and in the control subject with the 15qll-ql3 duplication, indicating the presence of extra and active chromosome 15qll-ql3 material (see Figure 1 ). FISH analysis with the SNRPN probe showed the presence of two in situ hybridization signals on the abnormal chromosome 15 indicating that the duplication included the SNRPN locus. The supernumerary marker chromosome 15 in the autistic male involved the 15q11-q13 region of maternal origin. FISH analysis showed the presence of two in situ hybridization signals for SNRPN in the supernumerary marker 15 chromosome confirming the presence of two 15ql1-q13 regions and only one signal in each of the two normal appearing chromosome 15s (data not shown). DNA microsatellites from the 15qll-ql3 region showed three DNA bands for the autistic male subject (two from the mother and one from the father), although the control subject with the de novo 15qll-ql3 duplication was also of maternal origin by DNA microsatellite studies (data not shown). The explanation for the apparent increased SNRPN gene expression signal in our two control subjects with extra chromosome 15 material of maternal origin is unknown. Possibly, the extra genetic material may have escaped the imprinting process by altering chromatin structure, or the imprinting center is unduplicated and cannot control the expression of excess genetic information in the tissue studied.
The subject with the de novo balanced reciprocal chromosomal translocation of paternal origin involving chromosomes 15 and 19 [t( 15;19)(q12;q13.41 )I reported previously by Sun et al.23 had features consistent with PWS. The chromosome breakpoint occurred within the SNRPN gene (between the second and third exons), and genes distal to the breakpoint were translocated to chromosome 19, leaving the imprinting center intact on chromosome 15. Normal expression was observed for the genes in the proximal long-arm of chromosome 15 translocated to chromosome 19, but no total intact SNRPN product was detected in this subject, further lending support to SNRPN gene as a key candidate gene for PWS.23
The PWS subjects with expression of the SNRPN gene [one deletion subject and one subject with maternal disomy 15 caused by a t(15;15)] and PARl transcript (one PWS patient with maternal disomy 15 and normal appearing chromosomes) was found upon repeated assays, when compared with the fibrillin gene. Repeated assays consisted of re-isolation of mRNA, production of cDNA, and RT-PCR from a new source of cells (e.g., a second lymphoblastoid cell line newly established but at a different time from the same subject). However, only recently established short-term lymphoblastoid cell lines were analyzed in 43 of the 48 subjects, and the gene expression in other tissues from these individuals is unknown. The explanation for the apparent increased SNRPN gene expression signal in our two control subjects with extra chromosome 15 material of maternal origin is unknown. However, the extra genetic material may have escaped the imprinting process because of chromatin structure rearrangement or possibly the instability of an unduplicated imprinting center to control the expression of the excess genetic information. There were no obvious differences identified during the initial clinical evaluation of those PWS patients showing expression of the SNRPN gene or the PAR1 transcript compared with those PWS subjects with no expression detectable for these genes or transcripts. PARl is the most distally located imprinted transcript of the five genes or transcripts analyzed in the 15qll-q13 region. Although the reason(s) for the weak expression of SNRPN gene or PARl transcript in these PWS subjects is unknown, possible explanations include relaxation of imprinting of the maternal chromosome 15 or undetected chromosome 15 mosaicism in the deletion PWS subjects. However, we have not found evidence of mosaicism by cytogenetic and molecular genetic studies with increased number of PCR cycles in the maternal disomy 15 or deletion PWS patients analyzed in this study (data not shown).
One control subject with normal appearing chromosomes (father of a PWS child with an imprinting mutation) lacked expression upon repeated assays of ZNF127, which is the most proximally located imprinted gene in the 15qll-ql3 region, but had complete expression of the fibrillin gene detected by RT-PCR (see Figure 1 ). Normal gene expression was found as expected for the remaining imprinted genes and transcripts studied in this subject. The degree of DNA methylation at several 15qll-ql3 loci may play a role in partial expression of the imprinted genes. However, discrepancies in gene expression in the 15qll-ql3 region may stimulate further research to unravel the molecular mechanisms involved in imprinting and pathogenesis of PWS.
Partial expression of imprinted DNA bands has been associated with neoplastic conditions such as W h s tumor, and recently Rogan et al.30 reported two unrelated PWS subjects with maternal disomy 15 whose cells expressed imprinted genes or transcripts (i.e., ZNF127, IPW, PAR5). Both patients were diagnosed with PWS during infancy but did not exhibit hyperphagia in childhood. In both patients the imprint switch appeared to occur correctly at SNRPN but did not occur at adjacent loci or was not maintained in either patient. They proposed that relaxation of imprinting could be caused by the failure to reset the imprint in the maternal germ line or to postzygotic gene expression. Therefore, there is evidence of imprinted genes or transcripts that are usually not expressed in PWS to be transcribed in a subset of patients with maternal disomy 15.
